WorstPills.org - Search Results for glimepiride (AMARYL)

An expert, independent second opinion on more than 1,800 prescription drugs, over-the-counter medications, and supplements

Search Type: drug or dietary supplement name
Search Term: glimepiride (AMARYL)

Worst Pills, Best Pills Newsletter Articles

Drug and Dietary Supplement Profiles

A comprehensive review of the safety and effectiveness of this drug. If the drug is not a Do Not Use product, information on adverse effects, drug interactions and how to use the medication are included.

Search results below include drug profiles where your selected drug is a primary subject of discussion

glimepiride (AMARYL); glipizide (GLUCOTROL, GLUCOTROL XL); glyburide (DIABETA, GLYNASE); tolazamide; tolbutamide

Disease and Drug Family Information

Search results below include Disease and Drug Family Information where your selected drug is a primary subject of discussion

Diabetes Prevention and Treatment [hide all summaries]
Diets that are very complicated or very different from what you are used to are hard to follow. The American Diabetes Association (ADA) diet is a highly structured plan based on exchange lists. Although it serves its purpose of regulating calorie and sugar intake quite well, the ADA diet may be difficult for older people to use. Successful use of this diet requires considerable time spent planning meal patterns and food portions. Older people often have trouble with this diet because the food lists are long and complicated and require considerable memorization.

Worst Pills, Best Pills Newsletter Articles

Search results below include Worst Pills, Best Pills Newsletter Articles where your selected drug is a primary subject of discussion

Preventing Heat-Induced Death and Illness [hide all summaries]
(June 2018)
This article lists practical steps to take to avoid death, hospitalization or other medical problems caused by heat stress. It also identifies over 100 drugs that can impair your response to heat and thereby increase your risk of heat-induced illness and death.
Drugs That Are Most Likely to Land Patients in the Emergency Room [hide all summaries]
(June 2017)
Many adverse drug reactions are severe enough to cause serious injury, hospitalization and even death. Find out which outpatient medications are most likely to cause adverse events that necessitate a visit to the emergency room.
Preventing Heat-Induced Death and Illness [hide all summaries]
(June 2012)
This article lists practical steps to take to avoid death, hospitalization or other medical problems caused by heat stress. It also contains a list of 123 drugs that can impair your response to heat.
Bladder Cancer Warning for Pioglitazone (ACTOS) [hide all summaries]
(November 2011)
Find out the full list of serious problems with pioglitazone (ACTOS) that cause it to be a DO NOT USE drug, of which bladder cancer is but the latest.
Review of Type-2 Diabetes Medication Liraglutide (VICTOZA) [hide all summaries]
(April 2011)
This article reviews the safety and efficacy of liraglutide (VICTOZA), a new medication used to treat type-2 diabetes.
Saxagliptin (ONGLYZA) - Another Diabetes Drug [hide all summaries]
(February 2011)
This article discusses why you should not use this newly approved diabetes drug until more is known about its safety.
Oral Drugs for Diabetes: Avoiding Hypoglycemia [hide all summaries]
(May 2010)
After explaining the symptoms of low blood sugar (hypoglycemia) the article lists 42 prescription drugs that can interact with one or more diabetes drugs to increase the chance of hypoglycemia.
Type 2 Diabetes Drugs Fail to Improve the Most Serious Long-Term Complications [hide all summaries]
(February 2010)
The article discusses why all of these 16 diabetes drugs carry a label stating: "There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction [heart attacks, strokes, etc] with oral antidiabetic drug[s]." The article also explains why lifestlyle changes such as diet and exercise to prevent or even treat type II diabetes are not heavily promoted or usually reimbursed.
A Review of Exenatide (BYETTA) for Type-2 Diabetes [hide all summaries]
(November 2009)
Because exenatide (BYETTA) is a new drug with increasing reports of severe, hospitalization-requiring pancreatitis and offers no significant breakthrough compared to other diabetes drugs, we urge readers not to use it until 2012--seven years after its approval, by which time much more will be known about its dangers.

SHOW secondary search results for glimepiride (AMARYL)